Vogelaar, Ingrid P
van der Post, Rachel S
van Krieken, J Han JM
Spruijt, Liesbeth
van Zelst-Stams, Wendy AG
Kets, C Marleen
Lubinski, Jan
Jakubowska, Anna
Teodorczyk, Urszula
Aalfs, Cora M
van Hest, Liselotte P
Pinheiro, Hugo
Oliveira, Carla
Jhangiani, Shalini N
Muzny, Donna M
Gibbs, Richard A
Lupski, James R
de Ligt, Joep http://orcid.org/0000-0002-0348-419X
Vissers, Lisenka E L M
Hoischen, Alexander
Gilissen, Christian http://orcid.org/0000-0003-1693-9699
van de Vorst, Maartje
Goeman, Jelle J
Schackert, Hans K
Ranzani, Guglielmina N
Molinaro, Valeria
Gómez García, Encarna B
Hes, Frederik J http://orcid.org/0000-0002-3025-0882
Holinski-Feder, Elke
Genuardi, Maurizio http://orcid.org/0000-0002-7410-8351
Ausems, Margreet G E M
Sijmons, Rolf H
Wagner, Anja
van der Kolk, Lizet E
Bjørnevoll, Inga
Høberg-Vetti, Hildegunn
van Kessel, Ad Geurts
Kuiper, Roland P
Ligtenberg, Marjolijn J L
Hoogerbrugge, Nicoline
Article History
Received: 21 November 2016
Revised: 7 July 2017
Accepted: 18 July 2017
First Online: 6 September 2017
Competing interests
: JRL has stock ownership in 23andMe and Lasergen, is a paid consultant for Regeneron, and a coinventor on multiple United States and European patents related to molecular diagnostics for inherited neuropathies, eye diseases and bacterial genomic fingerprinting. The Department of Molecular and Human Genetics at Baylor College of Medicine derives revenue from the clinical exome sequencing offered in the Baylor Miraca Genetics Laboratory (BMGL; ExternalRef removed). The remaining authors declare no conflict of interest.